{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:29Z","timestamp":1790691389248,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1198,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["PRVOUK P24"],"award-info":[{"award-number":["PRVOUK P24"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["PROGRESS Q26"],"award-info":[{"award-number":["PROGRESS Q26"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","award":["MACC Fund Endowed Chair"],"award-info":[{"award-number":["MACC Fund Endowed Chair"]}],"id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41374-019-0271-4","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T10:57:52Z","timestamp":1560250672000},"page":"1572-1592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hepatic pathology and altered gene transcription in a murine model of acid ceramidase deficiency"],"prefix":"10.1016","volume":"99","author":[{"given":"Fabian P.S.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Molino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2249-9549","authenticated-orcid":false,"given":"Shauna","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Rybova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everett","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron M.","family":"Geurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia V.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Mckillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Medin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-019-0271-4_bib1","series-title":"Scriver's OMMBID (Online Metabolic and Molecular Basis of Inherited Diseases)","article-title":"Acid ceramidase deficiency: Farber lipogranulomatosis","author":"Levade","year":"2014"},{"key":"10.1038\/s41374-019-0271-4_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0845-z","article-title":"Acid ceramidase deficiency: Farber disease and SMA-PME","volume":"13","author":"Yu","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1038\/s41374-019-0271-4_bib3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/gim.2017.133","article-title":"A cross-sectional quantitative analysis of the natural history of farber disease: An ultra-orphan condition with rheumatologic and neurological cardinal disease features","volume":"20","author":"Zielonka","year":"2017","journal-title":"Genet Med"},{"key":"10.1038\/s41374-019-0271-4_bib4","first-page":"816","article-title":"Lipogranulomatosis; a new lipo-glycoprotein storage disease","volume":"24","author":"Farber","year":"1957","journal-title":"J Mt Sinai Hosp NY"},{"key":"10.1038\/s41374-019-0271-4_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1546-0096-5-15","article-title":"Farber disease: Clinical presentation, pathogenesis and a new approach to treatment","volume":"5","author":"Ehlert","year":"2007","journal-title":"Pediatr Rheumatol"},{"key":"10.1038\/s41374-019-0271-4_bib6","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/ajmg.a.37846","article-title":"Atypical presentation of infantile\u2010onset farber disease with novel ASAH1 mutations","volume":"170","author":"Kim","year":"2016","journal-title":"Am J Med Genet"},{"key":"10.1038\/s41374-019-0271-4_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1651-2227.1958.tb07665.x","article-title":"Disseminated lipogranulomatosis (farber's disease)","volume":"47","author":"Zetterstr\u00f6m","year":"1958","journal-title":"Acta Paediatr"},{"key":"10.1038\/s41374-019-0271-4_bib8","first-page":"274","article-title":"Farber disease diagnosed after liver transplantation","volume":"36","author":"Salo","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1038\/s41374-019-0271-4_bib9","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/ard.2005.048322","article-title":"Farber's disease without central nervous system involvement: Bone-marrow transplantation provides a promising new approach","volume":"65","author":"Ehlert","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/s41374-019-0271-4_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0022-3476(62)80257-1","article-title":"Farber's disease: Report of a case with observations on its histogenesis and notes on the nature of the stored material","volume":"61","author":"Abul-Haj","year":"1962","journal-title":"J Pediatr"},{"key":"10.1038\/s41374-019-0271-4_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00365517109080235","article-title":"Ceramides in a patient with lipogranulomatosis (farber's disease) with chronic course","volume":"27","author":"Samuelsson","year":"1971","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1038\/s41374-019-0271-4_bib12","first-page":"135","article-title":"Farber's disease (disseminated lipogranulomatosis) A pathological, histochemical and ultrastructural study","volume":"29","author":"Tanaka","year":"1979","journal-title":"Pathol Int"},{"key":"10.1038\/s41374-019-0271-4_bib13","first-page":"206A","article-title":"Farber's lipogranulomatosis: Variability of expression and clinical overlap with histiocytosis","volume":"17","author":"Antonarakis","year":"1983","journal-title":"Pediatr Res"},{"key":"10.1038\/s41374-019-0271-4_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2350\/07-08-0318.1","article-title":"Farber's disease type IV presenting with cholestasis and neonatal liver failure: Report of two cases","volume":"11","author":"Willis","year":"2008","journal-title":"Pediatr Dev Pathol"},{"key":"10.1038\/s41374-019-0271-4_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF01799842","article-title":"Bone marrow involvement and obstructive jaundice in farber lipogranulomatosis: Clinical and autopsy report of a new case","volume":"19","author":"Nowaczyk","year":"1996","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/s41374-019-0271-4_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jbior.2016.10.002","article-title":"Ceramidases, roles in sphingolipid metabolism and in health and disease","volume":"63","author":"Coant","year":"2017","journal-title":"Advances in biological regulation"},{"key":"10.1038\/s41374-019-0271-4_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/s41374-019-0271-4_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1018573518127","article-title":"\u0392eta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis","volume":"14","author":"Matsuda","year":"1997","journal-title":"Glycoconj J"},{"key":"10.1038\/s41374-019-0271-4_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI16010","article-title":"Defective TNF-\u03b1\u2013mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice","volume":"111","author":"Garc\u00eda-Ruiz","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/s41374-019-0271-4_bib20","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/s41374-019-0271-4_bib21","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/hep.23545","article-title":"Hepatic glycosphingolipid deficiency and liver function in mice","volume":"51","author":"Jennemann","year":"2010","journal-title":"Hepatology"},{"key":"10.1038\/s41374-019-0271-4_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/emmm.201202301","article-title":"Systemic ceramide accumulation leads to severe and varied pathological consequences","volume":"5","author":"Alayoubi","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1038\/s41374-019-0271-4_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3324\/haematol.2014.108530","article-title":"Markedly perturbed hematopoiesis in acid ceramidase deficient mice","volume":"100","author":"Dworski","year":"2015","journal-title":"Haematologica"},{"key":"10.1038\/s41374-019-0271-4_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbadis.2016.11.031","article-title":"Acid ceramidase deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy","volume":"1863","author":"Dworski","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1038\/s41374-019-0271-4_bib25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1152\/ajplung.00223.2017","article-title":"Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency","volume":"314","author":"Yu","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1038\/s41374-019-0271-4_bib26","article-title":"Deletion of MCP-1 impedes pathogenesis of acid ceramidase deficiency","volume":"8","author":"Yu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1038\/s41374-019-0271-4_bib27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.embor.7400208","article-title":"The complex life of simple sphingolipids","volume":"5","author":"Futerman","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1038\/s41374-019-0271-4_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: Lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/s41374-019-0271-4_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/BJ20111626","article-title":"Ceramide synthases at the centre of sphingolipid metabolism and biology","volume":"441","author":"Mullen","year":"2012","journal-title":"Biochem J"},{"key":"10.1038\/s41374-019-0271-4_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/diabetes.53.1.25","article-title":"Ceramide content is increased in skeletal muscle from obese insulin-resistant humans","volume":"53","author":"Adams","year":"2004","journal-title":"Diabetes"},{"key":"10.1038\/s41374-019-0271-4_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1152\/ajpendo.91014.2008","article-title":"Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome","volume":"297","author":"Yang","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/s41374-019-0271-4_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in fah\u2212\/\u2212\/Rag2\u2212\/\u2212\/Il2rg\u2212\/\u2212 mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1038\/s41374-019-0271-4_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/978-1-4419-6741-1_3","article-title":"Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS\/MS)","volume":"688","author":"Bielawski","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/s41374-019-0271-4_bib34","first-page":"e50615","article-title":"Isolation of human hepatocytes by a two-step collagenase perfusion procedure","volume":"79","author":"Lee","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1038\/s41374-019-0271-4_bib35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajpath.2016.12.005","article-title":"Acid ceramidase deficiency in mice results in a broad range of central nervous system abnormalities","volume":"187","author":"Sikora","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1038\/s41374-019-0271-4_bib36","first-page":"499","article-title":"A lipid metabolic disorder: Disseminated lipogranulomatosis; a syndrome with similarity to, and important difference from, niemann-pick and hand-schuller-christian disease","volume":"84","author":"Farber","year":"1952","journal-title":"AMA Am J Dis Child"},{"key":"10.1038\/s41374-019-0271-4_bib37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0022-3476(84)81106-3","article-title":"Phenotypic variability in siblings with farber disease","volume":"104","author":"Antonarakis","year":"1984","journal-title":"J Pediatr"},{"key":"10.1038\/s41374-019-0271-4_bib38","first-page":"54","article-title":"A case report of childhood farber's disease and literature review","volume":"55","author":"Bao","year":"2017","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1038\/s41374-019-0271-4_bib39","first-page":"34","article-title":"The abnormalities of lysosomal enzymes in mucopolysaccharidoses","volume":"7","author":"Hoof","year":"1968","journal-title":"The FEBS Journal"},{"key":"10.1038\/s41374-019-0271-4_bib40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/01913128709048433","article-title":"Farber's disease: A fine structural study","volume":"11","author":"Abenoza","year":"1987","journal-title":"Ultrastruct Pathol"},{"key":"10.1038\/s41374-019-0271-4_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10545-005-5671-5","article-title":"Acid sphingomyelinase deficiency. phenotype variability with prevalence of intermediate phenotype in a series of twenty-five czech and slovak patients. A multi-approach study","volume":"28","author":"Pavl\u016f-Pereira","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/s41374-019-0271-4_bib42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann\u2013Pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet Med"},{"key":"10.1038\/s41374-019-0271-4_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1038\/s41374-019-0271-4_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: No place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41374-019-0271-4_bib45","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.22890","article-title":"Hepatic stellate cells express functional CXCR4: Role in stromal cell\u2013derived factor-1\u03b1\u2013mediated stellate cell activation","volume":"49","author":"Hong","year":"2009","journal-title":"Hepatology"},{"key":"10.1038\/s41374-019-0271-4_bib46","first-page":"702","article-title":"CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice","volume":"308","author":"Wilson","year":"2015","journal-title":"Am J Physiol-Gastr L"},{"key":"10.1038\/s41374-019-0271-4_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051072","article-title":"Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model","volume":"18","author":"Salvalaio","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1038\/s41374-019-0271-4_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074912","article-title":"Gaucher disease: Transcriptome analyses using microarray or mRNA sequencing in a Gba1 mutant mouse model treated with velaglucerase alfa or imiglucerase","volume":"8","author":"Dasgupta","year":"2013","journal-title":"PloS One"},{"key":"10.1038\/s41374-019-0271-4_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"Wilkinson","year":"2012","journal-title":"PloS One"},{"key":"10.1038\/s41374-019-0271-4_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity","volume":"37","author":"Archer","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/s41374-019-0271-4_bib51","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1515\/hsz-2014-0301","article-title":"Innate immune responses in the brain of sphingolipid lysosomal storage diseases","volume":"396","author":"Vitner","year":"2015","journal-title":"Biol Chem"},{"key":"10.1038\/s41374-019-0271-4_bib52","first-page":"69","article-title":"Farber's disease (disseminated lipogranulomatosis): The first case reported in japan","volume":"32","author":"Ozaki","year":"1978","journal-title":"Acta Med Okayama"},{"key":"10.1038\/s41374-019-0271-4_bib53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1399-0004.1976.tb01624.x","article-title":"Familial lipogranulomatosis (farber's disease)","volume":"9","author":"Amirhakimi","year":"1976","journal-title":"Clin Genet"},{"key":"10.1038\/s41374-019-0271-4_bib54","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/BF00714300","article-title":"Farber disease with prolonged survival","volume":"16","author":"Fiumara","year":"1993","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/s41374-019-0271-4_bib55","doi-asserted-by":"crossref","first-page":"10880","DOI":"10.1074\/jbc.M109.081489","article-title":"Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver","volume":"285","author":"Bektas","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-019-0271-4_bib56","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1074\/jbc.M807800200","article-title":"Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice","volume":"284","author":"Deevska","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-019-0271-4_bib57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2337\/diabetes.54.3.591","article-title":"A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and cushing's syndrome","volume":"54","author":"Summers","year":"2005","journal-title":"Diabetes"},{"key":"10.1038\/s41374-019-0271-4_bib58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab"},{"key":"10.1038\/s41374-019-0271-4_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nat Med"},{"key":"10.1038\/s41374-019-0271-4_bib60","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab"},{"key":"10.1038\/s41374-019-0271-4_bib61","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbalip.2018.04.006","article-title":"Inactivation of ceramide synthase 2 catalytic activity in mice affects transcription of genes involved in lipid metabolism and cell division","volume":"1863","author":"Bickert","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1038\/s41374-019-0271-4_bib62","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1074\/jbc.M109.077610","article-title":"A critical role for ceramide synthase 2 in liver homeostasis II. insights into molecular changes leading to hepatopathy","volume":"285","author":"Pewzner-Jung","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-019-0271-4_bib63","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1038\/s41374-019-0271-4_bib64","doi-asserted-by":"crossref","first-page":"10902","DOI":"10.1074\/jbc.M109.077594","article-title":"A critical role for ceramide synthase 2 in liver homeostasis: I. Alterations in lipid metabolic pathways","volume":"285","author":"Pewzner-Jung","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-019-0271-4_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1388-1981(02)00341-4","article-title":"Sphingosine kinase, sphingosine-1-phosphate, and apoptosis","volume":"1585","author":"Maceyka","year":"2002","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1038\/s41374-019-0271-4_bib66","doi-asserted-by":"crossref","first-page":"30580","DOI":"10.1074\/jbc.274.43.30580","article-title":"Mass spectrometric identification of increased C16 ceramide levels during apoptosis","volume":"274","author":"Thomas","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-019-0271-4_bib67","doi-asserted-by":"crossref","first-page":"27879","DOI":"10.1074\/jbc.M503002200","article-title":"Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-\u03b1","volume":"280","author":"Osawa","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-019-0271-4_bib68","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2012.04.008","article-title":"A shift in sphingolipid composition from C24 to C16 increases susceptibility to apoptosis in HeLa cells","volume":"1821","author":"Sassa","year":"2012","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1038\/s41374-019-0271-4_bib69","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","article-title":"Secondary accumulation of gangliosides in lysosomal storage disorders","volume":"15","author":"Walkley","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"10.1038\/s41374-019-0271-4_bib70","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochimica et Biophysica Acta Mol Cell Res"},{"key":"10.1038\/s41374-019-0271-4_bib71","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ajpath.2011.04.017","article-title":"Endosomal\/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C","volume":"179","author":"Zhou","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1038\/s41374-019-0271-4_bib72","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00219682","article-title":"Prosaposin deficiency: Further characterization of the sphingolipid activator protein-deficient sibs","volume":"92","author":"radova","year":"1993","journal-title":"Hum Genet"},{"key":"10.1038\/s41374-019-0271-4_bib73","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/abbi.1994.1248","article-title":"Stimulation of acid ceramidase activity by saposin D","volume":"311","author":"Azuma","year":"1994","journal-title":"Arch Biochem Biophys"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0271-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0271-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722025843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722025843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0271-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:50:52Z","timestamp":1758397852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722025843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":73,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0023683722025843"],"URL":"https:\/\/doi.org\/10.1038\/s41374-019-0271-4","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic pathology and altered gene transcription in a murine model of acid ceramidase deficiency","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-019-0271-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}